Resources
Pharma’s Almanac December, 14, 2024 Read the full article >> Sonja Wustrack, Managing Director of Integrated Evidence Generation, OM1 The omnipresent dynamic of 2023 has been the decline in COVID, with patients, providers, and the pharma/biopharma industry adjusting to the aftermath of the pandemic. COVID-related deaths continue to fall, currently reaching levels seen in the very early days of[…]
Dermatology Times December 15, 2023 Stefan Weiss, MD, MBA, FAAD Read the full article >> 2023 brought exciting advances in the treatment of alopecia areata and vitiligo, autoimmune skin conditions that can significantly impact a person’s physical appearance and emotional well-being. The emergence of Janus kinase (JAK) inhibitors has shown tremendous promise as a novel[…]
Harness AI-Powered Digital Phenotyping for Personalized & Actionable Insights Read the ebook >> This ebook explores powerful insights and analyses that leverage AI models and digital phenotyping, built on patient data from a network of over 300 million lives, to generate personalized insights around: Treatments Diagnosis Utilization Risks Trials
Integrated evidence generation (IEG) is a framework for generating evidence to support regulatory decision-making in healthcare, automate real-world data collection and grow evergreening data networks that fuel a variety of needs.
OM1 is reimagining real-world evidence with the development of large, electronically connected networks of clinicians in key specialty areas. This ebook explores powerful insights, analyses, and use cases that leverage AI and data science from OM1’s Neuroscience Specialty Network. View ebook >>
